SREBF2 and central nervous system cancer: Furthermore, we compared the expression of SREBP2 in primary and recurrent gliomas of different grades and found that regardless of the grade, both in high and low-grade gliomas, the overall levels of SREBP2 as well as the proportion of SREBP2-n were increased in recurrent gliomas (Fig. 2g, h).